Seungtaek Lim

EASL Clinical Practice Guidelines on the management of hepatitis B virus infection

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release

Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib

Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer